Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
REATA PHARMACEUTICALS INC
CUSIP: 75615P103
Class: Common Stock
Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)
Note: Option positions (PUT/CALL) are excluded.
Q2 2023
Shares
100,430
Value ($000)
$10,240
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2023
100,430
$10,240
—
—